To determine the characteristics of clinical illness accompanying Plasmodium falciparum infection induced by controlled exposure to infected mosquitoes, records of 118 volunteers participating in studies conducted between 1985 and 1992 were reviewed. One hundred fourteen volunteers (97%) reported at least one symptom attributable to malaria, with fatigue, myalgias or arthralgias, headache, and chills most commonly reported. The median duration of symptoms was 3 days. Fever was recorded in 61% of volunteers; 4 volunteers had temperatures ú40ЊC. Neutropenia and thrombocytopenia were present in 9% and 12% of volunteers, respectively. Despite counts as low as 658/mL (neutrophils) or 73,000/mL (platelets), no secondary infectious or hemorrhagic complications occurred. In all cases, volunteers recovered completely and laboratory values returned to baseline after specific antimalarial therapy. Recrudescence did not occur in any volunteer. In this model, mosquito inoculation of P. falciparum is a reliable, safe, and well-tolerated method of experimental challenge.
Each record was reviewed for predefined symptoms (fever, Written informed consent was obtained from all volunteers, and all studies chills, fatigue, malaise, myalgias, arthralgias, headache, nausea, were conducted in accordance with guidelines established by and with the vomiting, diarrhea, abdominal pain), signs (maximum daily temapproval of the institutional review board at each of the study locations.
perature, pulse, blood pressure), and laboratory data (levels or signs, and laboratory data were recorded for all subjects. FurtherReprints or correspondence: Dr. Stephen L. Hoffman, Malaria Program, Naval Medical Research Institute, 12300 Washington Ave., Rockville, MD more, although several studies used symptom scales in an effort to 20852. quantitate the severity of symptoms, these scales were not uniform were generated using a statistics package (Excel; Microsoft, Red- additional patients were noted to have significant orthostatic blood pressure drops (ú10 mm Hg decline in systolic pressure Volunteers were infected by exposure to the bites of 1 -5 Anopheles stephensi or Anopheles freeborni mosquitoes subsewith accompanying symptoms) that responded to oral rehydration. One volunteer developed shortness of breath, beginning quently verified to carry sporozoites. The chloroquine-sensitive NF54 strain (n Å 78) [15] , the 3D7 (n Å 16) [16] and CVD1 2 days prior to the detection of parasitemia and persisting for 3 days, for which an etiology could not be determined. No (n Å 8) [17] clones of NF54, or the chloroquine-resistant 7G8 clone (n Å 16) [18] of P. falciparum were used in all chalpatient was found to have altered mental status or signs of cerebral malaria, and in no cases was hepatomegaly or splenolenges. Volunteers were evaluated daily by history, physical examination, and blood smear starting 5 -7 days after challenge megaly detected. Laboratory results. Changes in WBC count, hemoglobin and continuing until day 30; evaluations were then done weekly for an additional 4 -8 weeks.
level, and platelet count were assessed at baseline, the day of initial parasitemia, 36 -72 h after the first detection of paraSubjects were treated within the first 24 h of parasitemia (detected by thick blood film) in 110 of 117 infections; in 7 sitemia, and Ç3 weeks after the detection of parasitemia (table  3) . Significant declines in total WBC and platelet counts were volunteers participating in a doxycycline prophylaxis protocol [11], treatment was initiated 24 -72 h after the detection of noted, reaching a nadir 2 days after initiation of therapy (P õ .0001, 2-tailed t test, paired samples). In 10 of 83 volunteers, parasitemia. In 1 volunteer, parasites were never detected on blood smear, despite the presence of typical symptoms on days the WBC count was õ3000/mL (minimum, 1400/mL; normal range, 4000 -11,000/mL). The absolute neutrophil count was 14 -16; blood obtained on day 19 was culture-positive, and this individual was treated on day 30. Treatment regimens õ1000/mL in 7 of 79 subjects (minimum, 658/mL). Thrombocytopenia (platelet count õ100,000/mL) occurred in 10 of 83 consisted of oral chloroquine (600 mg initially, followed by 300 mg 6, 24, and 48 h later) with (n Å 22) or without (n Å 80) volunteers; the minimum recorded platelet count was 73,000/ 
mL.
No concurrent infections were reported in any of the volunfrom exposure until first symptoms) could not be determined for the group, as 42 of 118 patients were asymptomatic at the teers, and no bleeding episodes were reported. The mean hemoglobin level was slightly lower at all time points than baseline time parasitemia was detected and therapy started.
The maximum geometric mean parasitemia was 46 parasites/ values (table 3). The greatest decline recorded for a volunteer at any one time from baseline was 3.6 mg/dL; the lowest hemomL (range, 4-1848). The maximum level of parasitemia did not correlate with the duration of symptoms (r S Å .049, P ú .50) or globin value recorded after challenge was 11.8 mg/dL.
Two volunteers developed significant aminotransferase elethe height of the maximum temperature (r S Å .029, P ú .50) but correlated significantly with the total duration of parasitemia (r S vations (AST, 162 and 224 U/L; ALT, 314 and 353 U/L) at the time parasitemia was detected; these abnormalities returned Å .325, P õ .01). The median duration of parasitemia was 2 days (range, 1-7) once antimalarials were initiated, although parato baseline. No increase in alkaline phosphatase or serum bilirubin was recorded in these 2 volunteers. Serum electrolytes, sites were noted discontinuously for as long as 7 days in 1 volunteer [19] . No recrudescence occurred in any of the volunteers in BUN, and creatinine remained normal in all volunteers. Trace proteinuria was detected by dipstick in 10 of 72 volunteers at these studies. Subgroup comparisons. Comparisons of the laboratory and the time of the first positive smear.
Parasitemia. The mean prepatent period (time from exposymptom data between male and female volunteers yielded similar results, except that women had significantly lower levsure until first detected parasitemia) for all volunteers was 11.5 days (range, 7 -23); all 4 subjects with a prepatent period §20 els of parasitemia (34 vs. 156/mL, P Å .0009, 2-tailed t test assuming unequal variances) and a slightly shorter mean duradays were from 1 challenge group in one study, suggesting a difference in the infectivity of P. falciparum or a difference in tion of parasitemia (1.6 vs. 2.2 days, P Å .025). No differences were noted in the duration of symptoms, maximum temperathe efficiency of transmission by A. stephensi in this group. There was a negative correlation between the length of the ture, changes in hemoglobin level or white blood cell and platelet counts, maximum parasitemia, or prepatent period prepatent period and the number of infective bites (r S Å 0.343, P õ .001) but not the mean gland grade (defined in [3] ) of the when volunteers were grouped according to race (data not shown). There were no differences in symptoms, signs, or labobiting mosquitoes (r S Å .05, P ú .50). Incubation periods (time Table 3 . Mean values for white blood cell (WBC) count, platelet count, and hemoglobin level during the course of experimentally induced malaria. ratory data among patients challenged with NF54 (n Å 78), In the studies reviewed, onset of symptoms was as early as 6 days after challenge and as late as 23 days. Because not all 3D7 (n Å 16), CVDL (n Å 8), or 7G8 (n Å 16) parasites.
The frequency of gastrointestinal complaints (nausea, vompatients were symptomatic at the time of detection of parasitemia, an accurate incubation period could not be calculated. iting, diarrhea, or abdominal pain) did not differ between the three drug treatment regimens. The duration of nausea or vomIncubation periods in other studies of experimentally induced malaria have closely approximated the prepatent period, with iting in symptomatic volunteers infected with the 7G8 clone and receiving mefloquine was significantly longer (n Å 9; duraa mean of 12 days (range, 6 -17) observed by James et al. [22] and also 12 days (range, 10 -15) reported by Coatney et al. tion, 3.00 { 1.50 days) than in volunteers infected with NF54 or its clones who received chloroquine plus primaquine (n Å [24] . The mean prepatent period of 12 days (range, 6 -23) observed in the present series corresponds closely to those 9; duration, 1.67 { 1.66 days, P Å .0007) or chloroquine alone (n Å 29; duration, 1.46 { 0.69 days, P Å .0017, 2-tailed t test reported by Coatney et al. (11 days; range, 9 -13) [24] and Powell and McNamara (11 days; range, 9 -13, in volunteers assuming unequal variance).
bitten by 1 -5 infected mosquitoes) [26] .
In this series, we were able to confirm an inverse correlation Discussion between the number of infectious bites and the prepatent period. In the series reported by Powell and McNamara [26], a To better define the clinical course of experimentally induced P. falciparum malaria, we reviewed data collected from 18 significant difference was detected in the mean prepatent period in volunteers exposed to 1 -5 bites compared with ú10 bites independently conducted studies. Inherent in such a review are confounding factors that commonly plague metaanalysis:
(mean prepatent period, 11 vs. 7.6 days, respectively). The spectrum of symptoms exhibited by volunteers in the missing data and differences in study design, methodology, and data collection [20] . These differences may result in bias.
present series is similar to those seen in nonimmune persons who are naturally infected (table 1) . However, the volunteers Although interpretation of these data must, therefore, be viewed with caution, the findings are generally consistent with previous did not become as ill as do many patients who contract malaria under natural conditions of exposure. We believe that this was observations regarding clinical malaria.
Previous understanding of the clinical course of induced P. attributable to the fact that they were diagnosed and treated early in the course of illness, before the parasite burden had falciparum malaria has been derived from observations made during the use of malaria therapy for the treatment of neuroincreased significantly. The increase in frequency of symptoms and elevated temperatures after the initiation of chemotherapy syphilis, from antimalarial trials, and from studies of antimalarial resistance. Malaria therapy with Plasmodium vivax was first noted in this review (table 2) has not been a feature of previous reports, although most patients in other studies appear to have used systematically by Wagner-Jauregg [21] and was widely used in the United States and Europe in the prepenicillin era.
been more symptomatic at the time treatment was initiated than our volunteers were at any time. In an effort to induce more sustained and severe hyperthermia, some investigators substituted P. falciparum for P. vivax. Early
This increase in frequency of symptoms was not unique to any one treatment regimen; in particular, gastrointestinal efforts were marred by high mortality, but successive work lowered mortality to an ''acceptable'' level of 4% [22] . Unlike symptoms occurred with equal frequency with the three treatment regimens, which is probably representative of the frethe current challenge studies, the purpose of malaria therapy was to induce clinical illness, particularly fever ú40ЊC, and quency of these symptoms in acute malaria. Investigators involved in challenge studies in which mefloquine was used noted maintain illness as long as the condition of the patient permitted or until the malaria resolved spontaneously. Under these cirthat gastrointestinal side effects were more severe and vomiting more frequent than in studies relying on chloroquine. The incumstances, recrudescences were common (as a result of treatment with subcurative doses of quinine), in contrast to current creased duration of nausea and vomiting in volunteers treated with mefloquine is consistent with this observation, although methods, with which recrudescence has not been observed.
The next generation of observations on sporozoite-induced differences in the infecting P. falciparum strains is an alternative explanation. There are several possible explanations for P. falciparum malaria were made during studies of the clinical course of malaria and drug treatment studies [23, 24] . In these why clinical manifestations increased after initiation of treatment in some volunteers. One is that our screening procedure studies, it was common practice to allow volunteers to remain symptomatic and parasitemic for several days before treatment was so sensitive that, in a number of patients, we detected parasitemia before the parasites reached the threshold necessary was initiated. In one review of challenge studies, this translated into a mean parasite density of 88,713/mL [25], a result ú1000-to induce clinical manifestations and that subjects then developed symptoms and signs as they would have in the disease's fold higher than the mean parasite density observed in the present analysis. Despite these higher parasitemias and the natural history. Another explanation is that initiation of treatment in these subjects induced rupture of parasites and release greater severity of clinical manifestations, none of the ú2000 volunteers studied in this manner died as a direct result of of parasite ''toxins'' [27] , which led to the clinical manifestations. infection by P. falciparum.
In this series, platelet counts as low as 73,000/mL were atic for 4 days, suggesting that they were among the most ill patients in these studies. Both patients also reported nausea after observed without clinical manifestations. Thrombocytopenia, with counts as low as 20,000/mL, has been reported in up to starting chloroquine therapy but denied other gastrointestinal symptoms. Such symptoms have been reported to be frequent in 86% of naturally acquired P. falciparum infections [28] but has rarely been associated with evidence of bleeding diathesis P. falciparum infection when the liver enzymes are elevated but are not predictive of abnormal liver enzymes [31] . [29] . Platelet counts in the present series reached their nadir 2 days after the initial detection of parasitemia, coinciding with Experimental infection of volunteers with P. falciparum by the bite of 5 infected anopheline mosquitoes has proven to be the median time to parasite clearance. This finding is consistent with the hypothesis that hemolysis of parasitized red cells rea safe and reliable method for challenge. Although nearly all volunteers will be symptomatic, the illness is frequently mild. leases adenosine diphosphate, which leads to platelet activation [30] . Activated platelets are functional but have a shortened Detection of parasitemia reliably occurred at parasite densities of õ0.05%, a level 100-fold less than the parasitemia that life span; platelet counts could thus be expected to continue to decline after the last infected erythrocytes rupture, before defines severe malaria. No patient in this review met criteria for severe malaria and all recovered without sequelae. In addiclimbing back toward baseline.
Anemia was not a prominent feature in sporozoite-inoculated tion, no recrudescence of infection occurred, eliminating the risk of delayed clinical illness or secondary transmission. volunteers. Although hemoglobin values declined by as much as 3.6 mg/dL in 1 individual, no volunteer's hemoglobin level fell below 11.8 mg/dL. The patterns of rise and fall of hemoglobin levels varied considerably among the volunteers, and no Pathologic changes in the liver are a uniform feature of P. 
